NL8303980A - Farmaceutische preparaten met een effect ter regeling van de fagocyte functie. - Google Patents

Farmaceutische preparaten met een effect ter regeling van de fagocyte functie. Download PDF

Info

Publication number
NL8303980A
NL8303980A NL8303980A NL8303980A NL8303980A NL 8303980 A NL8303980 A NL 8303980A NL 8303980 A NL8303980 A NL 8303980A NL 8303980 A NL8303980 A NL 8303980A NL 8303980 A NL8303980 A NL 8303980A
Authority
NL
Netherlands
Prior art keywords
pepsin
human
enzyme
leukocyte
human leukocyte
Prior art date
Application number
NL8303980A
Other languages
English (en)
Dutch (nl)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of NL8303980A publication Critical patent/NL8303980A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8303980A 1982-11-20 1983-11-18 Farmaceutische preparaten met een effect ter regeling van de fagocyte functie. NL8303980A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20399082 1982-11-20
JP57203990A JPS5995221A (ja) 1982-11-20 1982-11-20 食細胞機能調節作用を有する医薬組成物

Publications (1)

Publication Number Publication Date
NL8303980A true NL8303980A (nl) 1984-06-18

Family

ID=16482949

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303980A NL8303980A (nl) 1982-11-20 1983-11-18 Farmaceutische preparaten met een effect ter regeling van de fagocyte functie.

Country Status (11)

Country Link
US (1) US4534966A (de)
JP (1) JPS5995221A (de)
AU (1) AU552756B2 (de)
CA (1) CA1204054A (de)
CH (1) CH657050A5 (de)
DE (1) DE3341760A1 (de)
FR (1) FR2536281B1 (de)
GB (1) GB2132481B (de)
IT (1) IT1174799B (de)
NL (1) NL8303980A (de)
SE (1) SE460825B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067531B2 (en) 2004-11-12 2011-11-29 The Zhabilov Trust Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
US8309072B2 (en) * 2004-11-12 2012-11-13 The Zhabilov Trust Irreversibly-inactivated pepsinogen fragments for modulating immune function
WO2007041285A2 (en) * 2005-09-29 2007-04-12 Viral Genetics, Inc. Complexes of inactivated pepsin fraction and heat shock protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR59346E (fr) * 1949-06-09 1954-05-24 Valise roulante
US2930736A (en) * 1957-01-07 1960-03-29 Nat Drug Co Stabilized trypsin compositions containing partially hydrolyzed gelatin and method of making
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
CA1181005A (en) * 1981-02-10 1985-01-15 Haruo Ohnishi Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
NL8220027A (nl) * 1982-02-09 1983-11-01 Mochida Pharm Co Ltd Therapeutisch middel voor de behandeling van allergische aandoeningen, immuno.complexziekten en tumoren.
AU8459882A (en) * 1982-05-31 1983-12-16 Mochida Pharmaceutical Co., Ltd. Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Also Published As

Publication number Publication date
DE3341760C2 (de) 1989-09-07
IT8349367A0 (it) 1983-11-21
SE8306384L (sv) 1984-05-21
CH657050A5 (de) 1986-08-15
FR2536281B1 (fr) 1989-05-12
FR2536281A1 (fr) 1984-05-25
SE8306384D0 (sv) 1983-11-18
AU2155483A (en) 1984-05-24
AU552756B2 (en) 1986-06-19
JPH0261925B2 (de) 1990-12-21
JPS5995221A (ja) 1984-06-01
GB8330810D0 (en) 1983-12-29
GB2132481B (en) 1987-02-11
SE460825B (sv) 1989-11-27
GB2132481A (en) 1984-07-11
DE3341760A1 (de) 1984-06-14
CA1204054A (en) 1986-05-06
US4534966A (en) 1985-08-13
IT1174799B (it) 1987-07-01

Similar Documents

Publication Publication Date Title
US4626536A (en) Compositions for combatting toxaemia
JPS62201822A (ja) 自己免疫性疾病の予防・治療剤
Williams et al. Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism
US20040146565A1 (en) First lipoprotein fraction and therapeutic compositions of same
GB2108387A (en) A pharmaceutical composition containing myeloperoxidase
NL8303980A (nl) Farmaceutische preparaten met een effect ter regeling van de fagocyte functie.
JPH02184632A (ja) 医薬組成物
US4379141A (en) Method for recovering myeloperoxidase and pharmaceutical composition containing myeloperoxidase as major constituent
Doll et al. Treatment with low-dose oral etoposide in patients with myelodysplastic syndromes
JP4006058B2 (ja) 多臓器不全予防及び／又は治療剤
JPH07505893A (ja) 免疫学的機能不全を伴う疾患の治療のための方法および組成物
US4867976A (en) H.I.V. treatment utilizing specific inhibitation of protein syntheses in a cell
NL8200509A (nl) Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
US4591504A (en) Human leucocyte pepsin-like enzyme as a therapeutic agent for treating allergic disorders and immune complex diseases
NL8220027A (nl) Therapeutisch middel voor de behandeling van allergische aandoeningen, immuno.complexziekten en tumoren.
CA2380908A1 (en) Plasma substitute composition
Kyle et al. Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma
RU1826911C (ru) Способ профилактики и лечени атеросклероза в эксперименте
JPH0378372B2 (de)
Younes et al. Cell-mediated cytotoxicity by natural killer and killer cells, lipid peroxidation and glutathione
Golper et al. Incomplete activation of intraperitoneal clindamycin phosphate during peritoneal dialysis
JPH0543347B2 (de)
US4874608A (en) Therapeutic method for treating malignancies
RU2166944C2 (ru) Плазмозамещающий раствор с гемокоррегирующими и иммуномодулирующими свойствами
Riley Whatever happened to the asparaginase concept of amino acid deprivation therapy?

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed
BV The patent application has lapsed